Skip to main content
main-content

Zeitschrift

Medical Oncology

Medical Oncology 5/2016

Ausgabe 5/2016

Inhaltsverzeichnis ( 15 Artikel )

01.05.2016 | Original Paper | Ausgabe 5/2016

Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer

Soni Kumari, Puneet, Shyam Babu Prasad, Suresh Singh Yadav, Mohan Kumar, A. Khanna, V. K. Dixit, Gopal Nath, Sunita Singh, Gopeshwar Narayan

01.05.2016 | Original Paper | Ausgabe 5/2016 Open Access

Hypoxia regulates stemness of breast cancer MDA-MB-231 cells

Jing Xie, Yong Xiao, Xiao-yan Zhu, Zhou-yu Ning, Hai-fan Xu, Hui-min Wu

01.05.2016 | Original Paper | Ausgabe 5/2016

BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer

Kuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, Jia-Huei Tsai, Li-Hui Tseng, Liang-In Lin, Jin-Tung Liang, Been-Ren Lin, Ji-Shiang Hung, Yih-Leong Chang, Kun-Huei Yeh, Ann-Lii Cheng

01.05.2016 | Original Paper | Ausgabe 5/2016

Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer

Tatsuya Takayama, Taro Kubo, Ai Morikawa, Tatsuo Morita, Osamu Nagano, Hideyuki Saya

01.05.2016 | Original Paper | Ausgabe 5/2016

FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation

Xinyu Liu, Xiaoqian Jing, Xi Cheng, Ding Ma, Zhijian Jin, Weiping Yang, Weihua Qiu

01.05.2016 | Original Paper | Ausgabe 5/2016

Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer

Daniel A. Goldstein, Kavya Krishna, Christopher R. Flowers, Bassel F. El-Rayes, Tanios Bekaii-Saab, Anne M. Noonan

01.05.2016 | Original Paper | Ausgabe 5/2016

Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study

Monika Migdalska-Sęk, Agata Karowicz-Bilińska, Dorota Pastuszak-Lewandoska, Karolina H. Czarnecka, Ewa Nawrot, Daria Domańska-Senderowska, Justyna Kiszałkiewicz, Ewa Brzeziańska-Lasota

01.05.2016 | Original Paper | Ausgabe 5/2016

Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma

Carmen Loquai, Dagmar Dechent, Marlene Garzarolli, Martin Kaatz, Katharina C. Kaehler, Peter Kurschat, Frank Meiss, Annette Stein, Dorothee Nashan, Oliver Micke, Ralph Muecke, Karsten Muenstedt, Christoph Stoll, Irene Schmidtmann, Jutta Huebner

01.05.2016 | Original Paper | Ausgabe 5/2016

HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells

Zhihao Wang, Pengchao Hu, Fang Tang, Conghua Xie

01.05.2016 | Original Paper | Ausgabe 5/2016

Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib

Zammam Areeb, Stanley S. Stylli, Thomas M. B. Ware, Nicole C. Harris, Lipi Shukla, Ramin Shayan, Lucia Paradiso, Bo Li, Andrew P. Morokoff, Andrew H. Kaye, Rodney B. Luwor

01.05.2016 | Review Paper | Ausgabe 5/2016

Clinical significance of circulating miRNA detection in lung cancer

Chen Zhao, Funian Lu, Hongxia Chen, Fuqiang Zhao, Ziwen Zhu, Xianda Zhao, Honglei Chen

01.05.2016 | Review Paper | Ausgabe 5/2016

Multi-kinase inhibitors, AURKs and cancer

Jonas Cicenas, Erikas Cicenas

01.05.2016 | Review Paper | Ausgabe 5/2016

Targeting persistent androgen receptor signaling in castration-resistant prostate cancer

Laura Graham, Michael T. Schweizer

01.05.2016 | Review Article | Ausgabe 5/2016

Translating microRNAs into biomarkers: What is new for pediatric cancer?

Ivna Néria Silva Ribamar de Carvalho, Renata Mendes de Freitas, Fernando Regla Vargas

01.05.2016 | Short Communication | Ausgabe 5/2016

Peptide receptor radionuclide therapy for metastatic paragangliomas

David J. Pinato, James R. M. Black, Ramya Ramaswami, Tricia M. Tan, Delali Adjogatse, Rohini Sharma

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise